Visser LG - Search Results

1

S. typhi Vi capsular polysaccharide vaccine-induced humoral immunity in travellers with immunosuppressive therapy for rheumatoid disease.

von Asmuth EGJ, Brockhoff HJ, Wallinga J, Visser LG. von Asmuth EGJ, et al. Among authors: visser lg. J Travel Med. 2019 Jan 1;26(1). doi: 10.1093/jtm/tay073. J Travel Med. 2019. PMID: 30137469

2

Typhoid fever in group travelers: opportunity for studying vaccine efficacy.

Cobelens FG, Kooij S, Warris-Versteegen A, Visser LG. Cobelens FG, et al. Among authors: visser lg. J Travel Med. 2000 Jan;7(1):19-24. doi: 10.2310/7060.2000.00005. J Travel Med. 2000. PMID: 10689234 Free article.

3

Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine.

Gelinck LB, van der Bijl AE, Visser LG, Huizinga TW, van Hogezand RA, Rijkers GT, Kroon FP. Gelinck LB, et al. Among authors: visser lg. Vaccine. 2008 Jun 25;26(27-28):3528-33. doi: 10.1016/j.vaccine.2008.04.028. Epub 2008 May 2. Vaccine. 2008. PMID: 18502006

4

Hepatitis A vaccination in patients with rheumatic diseases and drug-induced immunosuppression.

Bühler S, Visser LG. Bühler S, et al. Among authors: visser lg. Travel Med Infect Dis. 2014 Mar-Apr;12(2):115-7. doi: 10.1016/j.tmaid.2014.02.003. Epub 2014 Feb 28. Travel Med Infect Dis. 2014. PMID: 24629802 No abstract available.

5

A case of delayed diagnosis of East-African trypanosomiasis in a Dutch traveller.

Wijsman CA, Hanssen JLJ, Scheper H, Visser LG, van Lieshout L. Wijsman CA, et al. Among authors: visser lg. J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay024. J Travel Med. 2018. PMID: 29688491

6

Defining malaria risk: it is not only about epidemiology but also about perception and risk threshold of travellers and policy makers.

Behrens RH, Hatz C, Visser L. Behrens RH, et al. J Travel Med. 2018 Jun 1;25(1). doi: 10.1093/jtm/tay043. J Travel Med. 2018. PMID: 29955875 No abstract available.

7

Managing invasive aspergillosis in haematological patients in the era of resistance polymerase chain reaction and increasing triazole resistance: A modelling study of different strategies.

van de Peppel RJ, van der Beek MT, Visser LG, de Boer MGJ, Wallinga J. van de Peppel RJ, et al. Among authors: visser lg. Int J Antimicrob Agents. 2019 Mar;53(3):284-293. doi: 10.1016/j.ijantimicag.2018.10.021. Epub 2018 Nov 2. Int J Antimicrob Agents. 2019. PMID: 30395989

8

Waning immunity after single-dose yellow fever vaccination: Who needs a second shot?

Visser LG, Veit O, Chen LH. Visser LG, et al. J Travel Med. 2019 Oct 14;26(7):tay134. doi: 10.1093/jtm/tay134. J Travel Med. 2019. PMID: 30476151 No abstract available.

9

Fractional-dose yellow fever vaccination: an expert review.

Roukens AHE, Visser LG. Roukens AHE, et al. Among authors: visser lg. J Travel Med. 2019 Sep 2;26(6):taz024. doi: 10.1093/jtm/taz024. J Travel Med. 2019. PMID: 30937437 Free PMC article. Review.

10

COVID-19 Immunity Passport to Ease Travel Restrictions?

Chen LH, Freedman DO, Visser LG. Chen LH, et al. Among authors: visser lg. J Travel Med. 2020 Aug 20;27(5):taaa085. doi: 10.1093/jtm/taaa085. J Travel Med. 2020. PMID: 32463093 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters